0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Successful management of locally advanced cervical cancer via total pelvic exenteration following neoadjuvant chemotherapy

      case-report

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Stage IVA cervical cancer is a tumor that invades the mucosa of the bladder or rectum without distant metastasis and is difficult to treat, and concurrent chemoradiotherapy is recommended. Although radical surgery following neoadjuvant chemotherapy is a treatment option for stage IVA cervical cancer, the evidence is limited. A 51-year-old woman with bulky cervical cancer and rectal invasion was referred to our hospital. Paclitaxel and cisplatin were administered as neoadjuvant chemotherapies. After two cycles of chemotherapy, the tumor size decreased markedly. Total pelvic exenteration was performed, and a complete resection was achieved. Four cycles of paclitaxel and cisplatin were administered postoperatively. Thirty-three months after the completion of adjuvant chemotherapy, the patient was alive and free of disease. Radical surgery after neoadjuvant chemotherapy may be a treatment option for stage IVA cervical cancer with bulky tumors.

          Related collections

          Most cited references13

          • Record: found
          • Abstract: not found
          • Article: not found

          Neoadjuvant Chemotherapy Followed by Radical Surgery Versus Concomitant Chemotherapy and Radiotherapy in Patients With Stage IB2, IIA, or IIB Squamous Cervical Cancer: A Randomized Controlled Trial

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study

            The concept of the use of MRI for image-guided adaptive brachytherapy (IGABT) in locally advanced cervical cancer was introduced 20 years ago. Here, we report on EMBRACE-I, which aimed to evaluate local tumour control and morbidity after chemoradiotherapy and MRI-based IGABT.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Tumour size, volume, and marker expression during radiation therapy can predict survival of cervical cancer patients: a multi-institutional retrospective analysis of KROG 16-01

                Bookmark

                Author and article information

                Contributors
                Journal
                J Surg Case Rep
                J Surg Case Rep
                jscr
                Journal of Surgical Case Reports
                Oxford University Press
                2042-8812
                July 2024
                11 July 2024
                11 July 2024
                : 2024
                : 7
                : rjae452
                Affiliations
                Department of Gynecology, Southern Tohoku General Hospital , 7-115 Yatsuyamada, Koriyama, Fukushima 963-8563, Japan
                Department of Reginal Gynecologic Oncology, Fukushima Medical University School of Medicine , 1 Hikarigaoka, Fukushima, Fukushima 960-1295, Japan
                Department of Reginal Gynecologic Oncology, Fukushima Medical University School of Medicine , 1 Hikarigaoka, Fukushima, Fukushima 960-1295, Japan
                Department of Obstetrics and Gynecology, Fukushima Medical University School of Medicine , 1-Hikarigaoka, Fukushima, Fukushima 960-1295, Japan
                Department of Gynecology, Southern Tohoku General Hospital , 7-115 Yatsuyamada, Koriyama, Fukushima 963-8563, Japan
                Department of Surgery, Southern Tohoku General Hospital , 7-115, Yatsuyamada, Koriyama, Fukushima 963-8563, Japan
                Department of Minimally Invasive Surgical and Medical Oncology, Fukushima Medical University School of Medicine , 1 Hikarigaoka, Fukushima, Fukushima 960-1295, Japan
                Department of Urology, Southern Tohoku General Hospital , 7-115 Yatsuyamada, Koriyama, Fukushima 963-8563, Japan
                Department of Obstetrics and Gynecology, Fukushima Medical University School of Medicine , 1-Hikarigaoka, Fukushima, Fukushima 960-1295, Japan
                Department of Regional Medical Support for Obstetrics and Gynecology, Fukushima Medical University School of Medicine , 1 Hikarigaoka, Fukushima, Fukushima 960-1295, Japan
                Department of Surgery, Southern Tohoku General Hospital , 7-115, Yatsuyamada, Koriyama, Fukushima 963-8563, Japan
                Department of Reginal Gynecologic Oncology, Fukushima Medical University School of Medicine , 1 Hikarigaoka, Fukushima, Fukushima 960-1295, Japan
                Department of Obstetrics and Gynecology, Fukushima Medical University School of Medicine , 1-Hikarigaoka, Fukushima, Fukushima 960-1295, Japan
                Department of Regional Medical Support for Obstetrics and Gynecology, Fukushima Medical University School of Medicine , 1 Hikarigaoka, Fukushima, Fukushima 960-1295, Japan
                Author notes
                Corresponding author. Department of Regional Gynecologic Oncology, Fukushima Medical University School of Medicine, 1, Hikarigaoka, Fukushima, Fukushima 960-1295, Japan. E-mail: yenyen@ 123456fmu.ac.jp
                Author information
                https://orcid.org/0000-0002-4227-0530
                Article
                rjae452
                10.1093/jscr/rjae452
                11238252
                38993818
                3278bd20-0b99-4a0a-b027-0cd6f7957dd8
                Published by Oxford University Press and JSCR Publishing Ltd. © The Author(s) 2024.

                This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com

                History
                : 29 May 2024
                : 29 June 2024
                Page count
                Pages: 0
                Categories
                Case Report
                AcademicSubjects/MED00910
                jscrep/060

                uterine cervical cancer,pelvic exenteration,radical surgery,neoadjuvant chemotherapy

                Comments

                Comment on this article